Core Points - The AMAC Wholesale Retail Trade Index increased by 1.07%, reaching 1700.32 points, with a trading volume of 34.214 billion yuan [1] - The index has risen by 2.06% over the past month, 5.71% over the past three months, and 6.13% year-to-date [1] Group 1: Index Composition - The AMAC Wholesale Retail Trade Index is based on 43 industry classification indices, excluding manufacturing, and is compiled according to the classification guidelines of the China Securities Association [1] - The top ten holdings in the index include Huadong Medicine (4.85%), Digital China (2.99%), Yonghui Superstores (2.86%), and others [1] Group 2: Market Segmentation - The Shenzhen Stock Exchange accounts for 54.80% of the index holdings, while the Shanghai Stock Exchange accounts for 45.20% [1] - In terms of industry composition, discretionary consumption represents 38.58%, healthcare 30.36%, and industrials 23.73% of the index [2]

● 优先股代码：360047 ● 优先股简称：九州优 ● 优先股面值：100元/股 ● 每股优先股派发现金股息：人民币5.00元（含税） ● 最后交易日：2025年8月8日（星期五） ● 股权登记日：2025年8月11日（星期一） ● 除息日：2025年8月11日（星期一） ● 股息发放日：2025年8月12日（星期二） 一、优先股股息派发审议情况 1、计息期间：2024年8月12日至2025年8月11日； 2、最后交易日：2025年8月8日（星期五）； 3、股权登记日：2025年8月11日（星期一）； 4、除息日：2025年8月11日（星期一）； 5、股息发放日：2025年8月12日（星期二）； 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容的 真实性、准确性和完整性承担法律责任。 重要内容提示： 九州通医药集团股份有限公司（以下简称"公司"）2022年第二次临时股东大会审议通过了《关于公司非 公开发行优先股方案的议案》，授权董事会在股东会审议通过的框架和原则下，依照发行文件的约定， 宣派和支付全部优先股股息。2025年6月17日，公司召开第六届董事会第十五次会议， ...

Core Viewpoint - 九州通医药集团股份有限公司 announced the implementation of the preferred stock dividend distribution plan, with a cash dividend of RMB 5.00 per share (including tax) based on a 5.00% coupon rate [1][4]. Summary by Sections Preferred Stock Dividend Distribution Review - The company’s second extraordinary general meeting in 2022 approved the non-public issuance of preferred shares and authorized the board to declare and pay all preferred stock dividends according to the issuance documents [1]. - The board meeting on June 17, 2025, approved the preferred stock dividend distribution plan [1]. Preferred Stock Dividend Distribution Plan - The interest calculation period starts from the payment deadline of the preferred stock issuance, with annual payment dates on the anniversary of the payment deadline [1]. - The dividend will be distributed on August 12, 2025, with the interest period from August 12, 2024, to August 11, 2025 [1]. Dividend Distribution Details - The dividend distribution is for 17.9 million shares, totaling RMB 89,500,000 (including tax) at a rate of RMB 5.00 per share [4]. - Tax obligations for cash dividends will be borne by the shareholders according to relevant regulations [4]. Important Dates - Last trading day: August 8, 2025 [2][3] - Record date: August 11, 2025 [2][3] - Ex-dividend date: August 11, 2025 [2][3] - Dividend payment date: August 12, 2025 [2][3].

证券代码：600998 证券简称：九州通 公告编号：临 2025-058 九州通医药集团股份有限公司 优先股 2025 年股息派发实施公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 九州通医药集团股份有限公司（以下简称"公司"）2022 年第二次临时股东 大会审议通过了《关于公司非公开发行优先股方案的议案》，授权董事会在股东 会审议通过的框架和原则下，依照发行文件的约定，宣派和支付全部优先股股息。 ，同意按照 5.00%的票面股息率（票面面值为 100 司优先股股息派发方案的议案》 ，向优先股股东派发股息每股 5.00 元（含税） 元/股） （详见公司公告：临 2025-047）。 二、优先股股息派发方案 根据公司披露的《九州通向特定对象发行优先股募集说明书》约定，计息起 始日为公司本次优先股发行的缴款截止日，每年的付息日为本次优先股发行的缴 款截止日起每满一年的当日，如该日为法定节假日或休息日，则顺延至下一个工 作日。九州优将于 2025 年 8 月 12 日实施本次股息发放，具体实施日期如下： 登记结算 ...

Group 1 - The Chengdu Qingyang District Health Bureau announced the procurement results for automatic external defibrillators (AEDs) for public places in 2025, with Sichuan Jiuzhoutong Medical Equipment Supply Chain Management Co., Ltd. winning the bid [1][2] - The total bid amount for the procurement project is 3,686,320.00 yuan, with a total score of 99.80 in the evaluation [3][2] - The company will supply 176 sets of Mindray's AEDs at a unit price of 16,980.00 yuan and 176 sets of Meisen's intelligent AED cases at a unit price of 3,965.00 yuan [3][1] Group 2 - Sichuan Jiuzhoutong Medical Equipment Supply Chain Management Co., Ltd. was established in 2023 with a registered capital of 60 million yuan and is a subsidiary of Jiuzhoutong Pharmaceutical Group Co., Ltd. [4] - The actual controller of the company holds a voting power of 51% and a total shareholding ratio of 9.7482% [5]

二、优先股股息派发方案 根据公司披露的《九州通向特定对象发行优先股募集说明书》约定，计息起 证券代码：600998 证券简称：九州通 公告编号：临 2025-058 九州通医药集团股份有限公司 优先股 2025 年股息派发实施公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、优先股股息派发审议情况 九州通医药集团股份有限公司（以下简称"公司"）2022 年第二次临时股东 大会审议通过了《关于公司非公开发行优先股方案的议案》，授权董事会在股东 会审议通过的框架和原则下，依照发行文件的约定，宣派和支付全部优先股股息。 2025 年 6 月 17 日，公司召开第六届董事会第十五次会议，审议通过了《关于公 司优先股股息派发方案的议案》，同意按照 5.00%的票面股息率（票面面值为 100 元/股），向优先股股东派发股息每股 5.00 元（含税）（详见公司公告：临 2025-047）。 全体优先股股东的股息由公司自行发放。 四、有关咨询方式 1、联系部门：公司董事会秘书处 1 优先股代码：360047 优先股简称： ...

Group 1: Tablet Market Overview - Global tablet shipments are projected to reach 39 million units in Q2 2025, marking a 9% year-on-year increase and a 5% quarter-on-quarter increase, driven by stable demand in China and EMEA regions [1] - Apple remains the market leader with 14.1 million iPads shipped in Q2 2025, a 2% increase year-on-year, while Samsung follows with 6.7 million units [3] - The strong performance of the tablet market is attributed to consumer subsidy policies in China and commercial tender projects globally, alongside a wave of new product launches, particularly in the gaming tablet segment [3] Group 2: Chromebook Market Dynamics - The Chromebook market is experiencing a resurgence, particularly in Japan, where shipments have increased over 20 times due to the GIGA school project, with expectations for this demand peak to continue until mid-2026 [5] - Lenovo leads the global Chromebook market with shipments of 3.45 million units in the first half of 2025, a 27% year-on-year increase, while HP follows with 2.59 million units, experiencing a slight decline [6] - Acer and ASUS also show positive growth, with Acer achieving a 10% increase in shipments to 2.22 million units and ASUS seeing a 43% increase to 0.84 million units, driven by the GIGA project [5][6]

Company Formation - Kyushu Tong Xinkang (Shanghai) Medical Equipment Co., Ltd. has been established with a registered capital of 20 million yuan [1] - The legal representative of the company is Wang Ling, and it is located in Chongming District, Shanghai [2] Business Scope - The company's business scope includes the operation of Class III medical devices, pharmaceutical wholesale, sales of disinfectants (excluding hazardous chemicals), daily necessities sales, and cosmetics wholesale [1][2] - Additional activities include sales of first and second-class medical devices, import and export of goods and technology, and various consulting services [2] Shareholding Structure - Kyushu Tong Xinkang is jointly held by Kyushu Tong Medical Equipment Group Co., Ltd. and other entities, with Kyushu Tong Medical Equipment Group holding a 51% stake [3] - Kyushu Tong Pharmaceutical Group Co., Ltd. is the major shareholder with an 81.42% stake, contributing approximately 315 million yuan [3]

Company Overview - Xiamen Jiuzhoutong Medical Supply Chain Management Co., Ltd. was recently established with a registered capital of 5 million RMB [1][2] - The legal representative of the company is Gao Qianjun, and it is wholly owned by Fujian Jiuzhoutong Medical Supply Chain Management Co., Ltd. [1][2] Business Scope - The company’s business scope includes supply chain management services, sales of Class I and Class II medical devices, chemical products sales (excluding licensed chemical products), cosmetics wholesale and retail, daily necessities sales, health consulting services (excluding diagnostic services), and enterprise management [1] - Additional services include machinery equipment leasing, social and economic consulting, information consulting (excluding licensed information consulting), translation services, low-temperature warehousing (excluding hazardous chemicals), general cargo warehousing (excluding hazardous chemicals), software sales and development, technical services, and computer hardware and software sales [1] - The company is also involved in the sale and repair of specialized equipment, electrical equipment, and teaching models, as well as information system integration services and construction decoration materials sales [1] Licensing and Regulatory Compliance - The company is authorized to operate in several licensed areas, including the operation of Class III medical devices, leasing of Class III medical equipment, sales of disinfecting devices, and medical device internet information services [1] - All operations are subject to approval by relevant authorities, and specific business activities will be conducted in accordance with the approved documents or permits [1]

Group 1: Industry Overview - The Chinese pharmaceutical distribution market can be divided into three competitive tiers, with the first tier consisting of national wholesale giants such as China National Pharmaceutical Group, Shanghai Pharmaceuticals, China Resources Pharmaceutical, and Jiuzhoutong, all generating over 100 billion in revenue [1] - The retail pharmacy rankings show Dazhenlin at the top, followed by Guoyao Pharmacy and Yifeng Pharmacy, indicating significant changes in the top five rankings compared to the previous year [3] - The e-commerce segment is led by Ark Health's online pharmacy, which is pioneering a new H2H (Hospital To Home) smart healthcare model [4] Group 2: Strategic Analysis - The strategic cluster analysis of listed companies in the pharmaceutical distribution industry indicates that leaders such as China Resources Pharmaceutical, Shanghai Pharmaceuticals, Jiuzhoutong, and China National Pharmaceutical Group have revenues exceeding 100 billion and are well-established in the market [5] - The competitive landscape is characterized by intense competition, with numerous participants including wholesale and retail pharmaceutical companies, as well as brand operators entering the supply chain [7] Group 3: Competitive Forces - The analysis using Porter's Five Forces model reveals a highly competitive environment in the pharmaceutical distribution industry, with a quantification of competitive forces ranging from 0 (minimum) to 1 (maximum) [7]